acivicin has been researched along with Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akassoglou, K; Ang, KK; Arkin, MR; Baeten, KM; Bardehle, S; Bedard, C; Bruneau, BG; Green, AJ; Hanspers, K; Jiang, X; Machado, MR; Mendiola, AS; Merlini, M; Meyer-Franke, A; Meza-Acevedo, R; Petersen, MA; Pfaff, SJ; Pico, AR; Pleiss, MA; Rafalski, VA; Rios Coronado, PE; Ryu, JK; Thomas, R; Thomas, S; Tognatta, R; Wang, J; Williams, A; Wilson, C; Yan, Z; Zamvil, SS | 1 |
1 other study(ies) available for acivicin and Multiple Sclerosis
Article | Year |
---|---|
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Topics: Animals; Antioxidants; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Profiling; Gene Regulatory Networks; High-Throughput Screening Assays; Humans; Immunity, Innate; Isoxazoles; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microglia; Multiple Sclerosis; Neurogenic Inflammation; Oxidative Stress; Sequence Analysis, RNA; Single-Cell Analysis | 2020 |